Serum Level of Adiponectin as a Risk Marker for Cardiovascular and Type 2 Diabetes Mellitus Patients

Abstract

Adiponectin has anti-atherogenic and anti-inflammatory properties. its' study as a risk marker for Cardiovascular and type -2- diabetes mellitus patients. This study was done in the period from 1/7/2011 to 1/11/2012 in Al-Hussein hospital in Karballa government. The study groups were divided into four groups ,one is control ,the others were patients ( type -2- diabetic , type - 2- diabetic with cardiovascular and Cardiovascular diseases ) . The results were showed , there were lowering in fasting serum adiponectin hormone concentration for (three study groups ) with respect to than normal subjects , significant different ( p< 0.001 ). When use adiponectin measurement as a marker to limitation the kind of pathogenic case and from Least Significant different (L..S.D) a statistical system were observed there were highly significant different between DMII group compared to control group while there were medium significant different with (DMII- CVD and CVD) groups . The results indicated that there were no significant different between (DMII-CVD and CVD) groups. while there were a significant difference between(DMII -CVD and CVD) groups and control group less than previous group DMII .Therefore concentration of adiponectin were considered as predictor of incident of diabetes mellitus more than cardiovascular diseases.